• 13920 Citations
  • 50 Scopus h-Index
1978 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Ramesk K Ramanathan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 27 Similar Profiles
gemcitabine Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1978 2019

NCI Experimental Therapeutics-Clinical Trials Network with Phase 1 Emphasis

Haluska, P. R. J., Ramanathan, R., Adjei, A., Ramanathan, R. K. & Erlichman, C.

National Institutes of Health

4/7/143/31/19

Project: Research project

Pharmacokinetics
Clinical Trials
Antineoplastic Agents
Pharmaceutical Preparations
Therapeutics
Pancreatic Neoplasms
Research Personnel
Research
gemcitabine
Mucins

Research Output 1995 2019

1 Citation (Scopus)

A Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer

Ramanathan, R. K., Thomas, G. W., Khorana, A. A., Shah, S., Zhou, C., Wong, S., Cole, G., James, D. & Gabrail, N. Y., Jan 1 2019, In : Oncology (Switzerland).

Research output: Contribution to journalArticle

Open Access
gemcitabine
Factor VIIa
Pancreatic Neoplasms
Disease-Free Survival
Survival

Correction: A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer (British Journal of Cancer, (2019), 120, 2, (183-189), 10.1038/s41416-018-0343-z)

Gorbunova, V., Beck, J. T., Hofheinz, R. D., Garcia-Alfonso, P., Nechaeva, M., Gracian, A. C., Mangel, L., Fernandez, E. E., Deming, D. A., Ramanathan, R. K., Torres, A. H., Sullivan, D., Luo, Y. & Berlin, J. D., Jan 1 2019, In : British journal of cancer.

Research output: Contribution to journalComment/debate

Open Access
Colorectal Neoplasms
Placebos
Neoplasms
veliparib
2 Citations (Scopus)

Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial

Shroff, R. T., Javle, M. M., Xiao, L., Kaseb, A. O., Varadhachary, G. R., Wolff, R. A., Raghav, K. P. S., Iwasaki, M., Masci, P., Ramanathan, R. K., Ahn, D., Bekaii-Saab, T. & Borad, M. J., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journalArticle

gemcitabine
Biliary Tract Neoplasms
Nanoparticles
Cisplatin
Clinical Trials
13 Citations (Scopus)

Hepatocytes direct the formation of a pro-metastatic niche in the liver

Lee, J. W., Stone, M. L., Porrett, P. M., Thomas, S. K., Komar, C. A., Li, J. H., Delman, D., Graham, K., Gladney, W. L., Hua, X., Black, T. A., Chien, A. L., Majmundar, K. S., Thompson, J. C., Yee, S. S., O’Hara, M. H., Aggarwal, C., Xin, D., Shaked, A., Gao, M. & 9 others, Liu, D., Borad, M. J., Ramanathan, R. K., Carpenter, E. L., Ji, A., de Beer, M. C., de Beer, F. C., Webb, N. R. & Beatty, G. L., Mar 14 2019, In : Nature. 567, 7747, p. 249-252 4 p.

Research output: Contribution to journalLetter

Hepatocytes
Liver
STAT3 Transcription Factor
Neoplasm Metastasis
Circulating Neoplastic Cells
3 Citations (Scopus)

Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313

Ramanathan, R. K., McDonough, S. L., Philip, P. A., Hingorani, S. R., Lacy, J., Kortmansky, J. S., Thumar, J., Chiorean, E. G., Shields, A. F., Behl, D., Mehan, P. T., Gaur, R., Seery, T., Guthrie, K. A. & Hochster, H. S., May 1 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 13, p. 1062-1069 8 p.

Research output: Contribution to journalArticle

Hyaluronoglucosaminidase
Adenocarcinoma
Hyaluronic Acid
Survival
irinotecan